ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China · Delayed Price · Currency is CNY 38.30
-0.35 (-0.91%)
At close: Feb 2, 2026
ChengDa Pharmaceuticals Revenue
ChengDa Pharmaceuticals had revenue of 102.64M CNY in the quarter ending September 30, 2025, with 28.69% growth. This brings the company's revenue in the last twelve months to 374.46M, down -5.87% year-over-year. In the year 2024, ChengDa Pharmaceuticals had annual revenue of 333.13M, down -19.59%.
Revenue (ttm)
374.46M
Revenue Growth
-5.87%
P/S Ratio
15.60
Revenue / Employee
616.90K
Employees
656
Market Cap
5.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 333.13M | -81.17M | -19.59% |
| Dec 31, 2023 | 414.30M | 2.84M | 0.69% |
| Jan 1, 2023 | 411.46M | -4.26M | -1.03% |
| Jan 1, 2022 | 415.73M | 42.69M | 11.44% |
| Dec 31, 2020 | 373.04M | 79.06M | 26.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition